Bayer, CureVac part ways on COVID-19 vaccine: reports
Bayer, CureVac part ways on COVID-19 vaccine: reports jkeenan Fri, [...]
Despite Merck’s oral COVID-19 drug, antibodies by Regeneron, GSK and others still have billions in sales ahead: analyst
Despite Merck’s oral COVID-19 drug, antibodies by Regeneron, GSK and [...]
Johnson & Johnson puts talc headache into bankruptcy; plaintiffs will contest the ploy
Johnson & Johnson puts talc headache into bankruptcy; plaintiffs will [...]
Fierce Pharma Asia—Takeda’s cell, gene therapy deals; BMS-BeiGene Abraxane brawl
Fierce Pharma Asia—Takeda’s cell, gene therapy deals; BMS-BeiGene Abraxane brawl [...]
FDA panel backs half-dose Moderna booster for the elderly and others at high risk
FDA panel backs half-dose Moderna booster for the elderly and [...]
Moderna criticized for COVID-19 vaccine strategy putting once feel-good success story in jeopardy
Moderna criticized for COVID-19 vaccine strategy putting once feel-good success [...]
Johnson & Johnson, Moderna COVID-19 vaccines work as intended, FDA staff say ahead of high-stakes booster meeting
Johnson & Johnson, Moderna COVID-19 vaccines work as intended, FDA [...]
ECTRIMS: Roche touts 8-year Ocrevus data to defend multiple sclerosis leadership
ECTRIMS: Roche touts 8-year Ocrevus data to defend multiple sclerosis [...]
Merck started its Acceleron pursuit at $160 per share, but CEO Davis balked at paying more than $180
Merck started its Acceleron pursuit at $160 per share, but [...]
Spinoff or $54B sale? GlaxoSmithKline’s consumer health outfit draws buyout interest: report
Spinoff or $54B sale? GlaxoSmithKline’s consumer health outfit draws buyout [...]